Therapeutic angiogenesis for cardiovascular disease
<p>Abstract</p> <p>The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have...
Main Authors: | D'Amore Patricia A, Ng Yin-Shan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2001-10-01
|
Series: | Current Controlled Trials in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1186/cvm-2-6-278 |
Similar Items
-
Modern concepts in angiogenesis /
by: 295065 Simons, Michael, et al.
Published: (2007) -
Aberrant angiogenesis: The gateway to diabetic complications
by: Sunil K Kota, et al.
Published: (2012-01-01) -
Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization
by: Lee JE, et al.
Published: (2017-07-01) -
Effects of expressions of VEGF, VEGF ⁃ C, VEGFR ⁃ 3 on interstitial angiogenesis and tumor cell proliferation in human gliomas
by: Su⁃qin CHEN, et al.
Published: (2010-08-01) -
Research on soluble VEGF receptor 1 in retinal neovascularization
by: Xiao-Yuan Cui, et al.
Published: (2018-03-01)